SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about audio recording of earnings call

25 Jan 2023 Evaluate

Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Strides Pharma Science has informed it enclosed the link of audio recording of earnings call pertaining to the financial results of the company for the quarter and nine months ended December 31, 2022 held on Tuesday, January 24, 2023. The Results were approved by the Board at its meeting held on January 24, 2023. The same can also be accessed on the Company’s website at: https://www.strides.com/investor-annualreport.html.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1155.85 11.30 (0.99%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×